Salmonella enterica serovar typhimurium ΔmsbB triggers exacerbated inflammation in Nod2 deficient mice

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Claes, Anne Kathrin ^a,b   Steck, Natalie ^a,b   Schultz, Dorothee ^a,b   Zähringer, Ulrich ^b   Lipinski, Simone ^a   Rosenstiel, Philip ^a   Geddes, Kaoru ^c   Philpott, Dana J ^c   Heine, Holger ^b   Grassl, Guntram A ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MSBB PROTEIN; PROTEIN N MYRISTOYLTRANSFERASE; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARD15 PROTEIN, MOUSE; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; C57BL 6 MOUSE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE MIGRATION; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; SALMONELLA TYPHIMURIUM; TYPHLITIS; ANIMAL; C57BL MOUSE; GENETICS; KNOCKOUT MOUSE; MICROBIOLOGY; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA;

MUS; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; HEK293 CELLS; HUMANS; INFLAMMATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NOD2 SIGNALING ADAPTOR PROTEIN; REAL-TIME POLYMERASE CHAIN REACTION; SALMONELLA ENTERICA;

EID: 84913603865     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113645     Document Type: Article

References (43)

1. Broz P, Ohlson MB, Monack DM (2012) Innate immune response to Salmonella typhimurium, a model enteric pathogen. Gut Microbes 3: 62-70. doi:10.4161/gmic.19141
2. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, et al. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278: 8869-8872. doi:10.1074/jbc.C200651200
3. Girardin SE, Boneca IG, Carneiro LAM, Antignac A, Jéhanno M, et al. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587. doi:10.1126/science.1084677
4. Kufer TA, Banks DJ, Philpott DJ (2006) Innate immune sensing of microbes by Nod proteins. Ann N Y Acad Sci 1072: 19-27. doi:10.1196/annals.1326.020
5. Geddes K, Rubino S, Streutker C, Cho JH, Magalhaes JG, et al. (2010) Nod1 and Nod2 regulation of inflammation in the Salmonella colitis model. Infect Immun 78: 5107-5115. doi:10.1128/IAI.00759-10
6. Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE (2014) NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14: 9-23. doi:10.1038/nri3565
7. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. (2001) Association of NOD2 leucinerich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
8. Wang YF, Zhang H, Ouyang Q (2007) Clinical manifestations of inflammatory bowel disease: East and West differences. J Dig Dis 8: 121-127. doi:10.1111/j.1443-9573.2007.00296.x
9. Barreau F, Madre C, Meinzer U, Berrebi D, Dussaillant M, et al. (2010) Nod2 regulates the host response towards microflora by modulating T cell function and epithelial permeability in mouse Peyer's patches. Gut 59: 207-217. doi:10.1136/gut.2008.171546
10. Hiemstra IH, Bouma G, Geerts D, Kraal G, den Haan JMM (2012) Nod2 improves barrier function of intestinal epithelial cells via enhancement of TLR responses. Mol Immunol 52: 264-272. doi:10.1016/j.molimm.2012.06.007
11. Selvanantham T, Escalante NK, Cruz Tleugabulova M, Fiévé S, Girardin SE, et al. (2013) Nod1 and Nod2 enhance TLR-mediated invariant NKT cell activation during bacterial infection. J Immunol 191: 5646-5654. doi:10.4049/jimmunol.1301412
12. Richardson WM, Sodhi CP, Russo A, Siggers RH, Afrazi A, et al. (2010) Nucleotide-binding oligomerization domain-2 inhibits toll-like receptor-4 signaling in the intestinal epithelium. Gastroenterology 139: 904-917, 917.e1-6. doi:10.1053/j.gastro.2010.05.038
13. Tsai W-H, Huang D-Y, Yu Y-H, Chen C-Y, Lin W-W (2011) Dual roles of NOD2 in TLR4-mediated signal transduction and -induced inflammatory gene expression in macrophages. Cell Microbiol 13: 717-730. doi:10.1111/j.1462-5822.2010.01567.x
14. Hedl M, Li J, Cho JH, Abraham C (2007) Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc Natl Acad Sci USA 104: 19440-19445. doi:10.1073/pnas.0706097104
15. Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, et al. (1994) Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 8: 217-225.
16. Khan SA, Everest P, Servos S, Foxwell N, Zähringer U, et al. (1998) A lethal role for lipid A in Salmonella infections. Mol Microbiol 29: 571-579.
17. Matsuura M, Kawasaki K, Kawahara K, Mitsuyama M (2012) Evasion of human innate immunity without antagonizing TLR4 by mutant Salmonella enterica serovar Typhimurium having penta-acylated lipid A. Innate Immun 18: 764-773. doi:10.1177/1753425912440599
18. Bohnhoff M, Drake BL, Miller CP (1954) Effect of streptomycin on susceptibility of intestinal tract to experimental Salmonella infection. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY 86: 132-137.
19. Barthel M, Hapfelmeier S, Quintanilla-Martinez L, Kremer M, Rohde M, et al. (2003) Pretreatment of mice with streptomycin provides a Salmonella enterica serovar Typhimurium colitis model that allows analysis of both pathogen and host. Infection and immunity 71: 2839-2858.
20. Hormaeche CE (1979) Natural resistance to Salmonella typhimurium in different inbred mouse strains. Immunology 37: 311-318.
21. Kobayashi KS, Chamaillard M, Ogura Y, Henegariu O, Inohara N, et al. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307: 731-734. doi:10.1126/science.1104911
22. Grassl GA, Valdez Y, Bergstrom KSB, Vallance BA, Finlay BB (2008) Chronic enteric Salmonella infection in mice leads to severe and persistent intestinal fibrosis. Gastroenterology 134: 768-780. doi:10.1053/j.gastro.2007.12.043
23. Liu T, Chopra AK (2010) An enteric pathogen Salmonella enterica serovar Typhimurium suppresses tumor growth by downregulating CD44high and CD4T regulatory (Treg) cell expression in mice: the critical role of lipopolysaccharide and Braun lipoprotein in modulating tumor growth. Cancer Gene Ther 17: 97-108. doi:10.1038/cgt.2009.58
24. Kong Q, Six DA, Liu Q, Gu L, Roland KL, et al. (2011) Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant. Infect Immun 79: 5027-5038. doi:10.1128/IAI.05524-11
25. Petnicki-Ocwieja T, Hrncir T, Liu YJ, Biswas A, Hudcovic T, et al. (2009) Nod2 is required for the regulation of commensal microbiota in the intestine. Proc Natl Acad Sci U S A 106: 15813-15818. doi:10.1073/pnas.0907722106
26. Kim Y-G, Kamada N, Shaw MH, Warner N, Chen GY, et al. (2011) The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes. Immunity 34: 769-780. doi:10.1016/j.immuni.2011.04.013
27. Divangahi M, Mostowy S, Coulombe F, Kozak R, Guillot L, et al. (2008) NOD2-deficient mice have impaired resistance to Mycobacterium tuberculosis infection through defective innate and adaptive immunity. J Immunol 181: 7157-7165.
28. Loetscher Y, Wieser A, Lengefeld J, Kaiser P, Schubert S, et al. (2012) Salmonella transiently reside in luminal neutrophils in the inflamed gut. PLoS ONE 7: e34812. doi:10.1371/journal.pone.0034812
29. Geddes K, Rubino SJ, Magalhaes JG, Streutker C, Le Bourhis L, et al. (2011) Identification of an innate T helper type 17 response to intestinal bacterial pathogens. Nat Med 17: 837-844. doi:10.1038/nm.2391
30. Schromm AB, Brandenburg K, Loppnow H, Moran AP, Koch MH, et al. (2000) Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem 267: 2008-2013.
31. Watanabe T, Kitani A, Murray PJ, Wakatsuki Y, Fuss IJ, et al. (2006) Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigenspecific colitis. Immunity 25: 473-485. doi:10.1016/j.immuni.2006.06.018
32. Kullberg BJ, Ferwerda G, de Jong DJ, Drenth JPH, Joosten LAB, et al. (2008) Crohn's disease patients homozygous for the 3020insC NOD2 mutation have a defective NOD2/TLR4 cross-tolerance to intestinal stimuli. Immunology 123: 600-605. doi:10.1111/j.1365-2567.2007.02735.x
33. Fritz JH, Girardin SE, Fitting C, Werts C, Mengin-Lecreulx D, et al. (2005) Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur J Immunol 35: 2459-2470. doi:10.1002/eji.200526286
34. Tada H, Aiba S, Shibata K-I, Ohteki T, Takada H (2005) Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 73: 7967-7976. doi:10.1128/IAI.73.12.7967-7976.2005
35. Netea MG, Ferwerda G, de Jong DJ, Jansen T, Jacobs L, et al. (2005) Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release. J Immunol 174: 6518-6523.
36. Borm MEA, van Bodegraven AA, Mulder CJJ, Kraal G, Bouma G (2008) The effect of NOD2 activation on TLR2-mediated cytokine responses is dependent on activation dose and NOD2 genotype. Genes Immun 9: 274-278. doi:10.1038/gene.2008.9
37. Hedl M, Abraham C (2011) Secretory mediators regulate Nod2-induced tolerance in human macrophages. Gastroenterology 140: 231-241. doi:10.1053/j.gastro.2010.09.009
38. Hedl M, Abraham C (2013) Negative regulation of human mononuclear phagocyte function. Mucosal Immunol 6: 205-223. doi:10.1038/mi.2012.139
39. Rubino SJ, Selvanantham T, Girardin SE, Philpott DJ (2012) Nod-like receptors in the control of intestinal inflammation. Curr Opin Immunol 24: 398-404. doi:10.1016/j.coi.2012.04.010
40. McGovern DPB, Hysi P, Ahmad T, van Heel DA, Moffatt MF, et al. (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14: 1245-1250. doi:10.1093/hmg/ddi135
41. Franke A, Ruether A, Wedemeyer N, Karlsen TH, Nebel A, et al. (2006) No association between the functional CARD4 insertion/deletion polymorphism and inflammatory bowel diseases in the German population. Gut 55: 1679-1680. doi:10.1136/gut.2006.104646
42. Hasegawa M, Yamazaki T, Kamada N, Tawaratsumida K, Kim Y-G, et al. (2011) Nucleotide-binding oligomerization domain 1 mediates recognition of Clostridium difficile and induces neutrophil recruitment and protection against the pathogen. J Immunol 186: 4872-4880. doi:10.4049/jimmunol.1003761
43. Le Bourhis L, Magalhaes JG, Selvanantham T, Travassos LH, Geddes K, et al. (2009) Role of Nod1 in mucosal dendritic cells during Salmonella pathogenicity island 1-independent Salmonella enterica serovar Typhimurium infection. Infect Immun 77: 4480-4486. doi:10.1128/IAI.00519-09